Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Phil Greenfield

Editor

London, UK

After studying engineering, Editor-In-Chief Phil Greenfield started reporting on the medtech sector as a science journalist in 1993, when digital health, TAVR and personalized medicine were pipe dreams. He has since worked across all areas of health-care publishing, as an editor, publisher and principal analyst, and has been responsible for launching intelligence-based products to medtech and pharma clients. Phil has written extensively on topics around diagnostic imaging, IVDs, cardiovascular devices, orthopedics, oncology, wound care, clinical trials and EU reimbursement, and has authored numerous market forecasting reports on subjects ranging from prostate cancer diagnostics and devices to transcatheter embolization systems. Phil has also recently worked as an independent consultant with medtech/healthtech companies and universities assessing markets and product opportunities. A keen cyclist and walker, he lives in Yorkshire, England, where the steep hills help him counterbalance his other loves of food and Belgian beer.


Latest From Phil Greenfield

Drug-Coated Balloon For Urethral Strictures Debuts In Europe, Version For BPH Planned

Urotronic set to complete a $20m series C, bringing its total funding to $61m for the development of drug-eluting balloon-based urology products.

Drug Delivery Research & Development

Infographic: Sleep Apnea Market To Reach Almost $10.3Bn By 2022

The market for devices to monitor and treat sleep apnea and its complications is set to grow by 7.3% annually in the next three years, with the US market expanding by 7.6% per year, according to the Meddevicetracker Dashboard.

Market Intelligence Respiratory

Start-Up Spotlight: OrthoSon Targets Back Pain With Ultrasound, Injectable Hydrogel Combo

The Oxford University spin-off has raised over £3m so far to develop its minimally invasive disc nucleus replacement technology and plans a £10m series A.

Research & Development Start-up Spotlight

Infographic: Glucose Monitor and Insulin Pump Markets To Reach A Combined $17.9Bn By 2023

The markets for glucose monitors and insulin pumps together have a four-year growth rate of over 12%, with the US markets expanding at a combined rate of 17.5% per year, according to the Meddevicetracker Dashboard.

Market Intelligence Diabetic Care

Infographic: Chronic Pain Market To Reach Almost $10Bn By 2024

The market for devices to treat chronic pain is set to grow by 4.9% annually to 2024, with the US market expanding by 5.5% per year, according to the Meddevicetracker Dashboard.

Market Intelligence Neurology

Nyxoah Plans $70M+ IPO As It Starts IDE Trial For Neurostim Apnea Device

Belgian firm will float on Euronext Brussels; ResMed and Cochlear among existing investors who will invest in at least 25% of shares.

Financing Companies
See All
UsernamePublicRestriction

Register